Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$241.42 - $282.29 $133,746 - $156,388
-554 Reduced 2.28%
23,721 $6.3 Million
Q3 2022

Oct 31, 2022

SELL
$247.06 - $1507.4 $63,988 - $390,416
-259 Reduced 1.06%
24,275 $6.27 Million
Q2 2022

Aug 01, 2022

BUY
$237.11 - $299.66 $919,038 - $1.16 Million
3,876 Added 18.76%
24,534 $6.22 Million
Q1 2022

May 04, 2022

BUY
$257.27 - $315.76 $5.31 Million - $6.52 Million
20,658 New
20,658 $6.06 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $709,762 - $819,687
-7,483 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $734,306 - $814,898
7,483 New
7,483 $813,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Leuthold Group, LLC Portfolio

Follow Leuthold Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.